Other valuable HCC biomarkers, such as hexokinase 2 (HK2) [67] and cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‐4),[68] should be further investigation. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.